GB9930696D0 - Novel method of treatment - Google Patents

Novel method of treatment

Info

Publication number
GB9930696D0
GB9930696D0 GBGB9930696.1A GB9930696A GB9930696D0 GB 9930696 D0 GB9930696 D0 GB 9930696D0 GB 9930696 A GB9930696 A GB 9930696A GB 9930696 D0 GB9930696 D0 GB 9930696D0
Authority
GB
United Kingdom
Prior art keywords
treatment
novel method
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9930696.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9930696.1A priority Critical patent/GB9930696D0/en
Publication of GB9930696D0 publication Critical patent/GB9930696D0/en
Priority to PCT/GB2000/005007 priority patent/WO2001047520A1/en
Priority to AU23827/01A priority patent/AU2382701A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
GBGB9930696.1A 1999-12-24 1999-12-24 Novel method of treatment Ceased GB9930696D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9930696.1A GB9930696D0 (en) 1999-12-24 1999-12-24 Novel method of treatment
PCT/GB2000/005007 WO2001047520A1 (en) 1999-12-24 2000-12-22 Thiazolidinedione derivatives in treatment of diabetes mellitus of type 2
AU23827/01A AU2382701A (en) 1999-12-24 2000-12-22 Thiazolidinedione derivatives in treatment of diabetes mellitus of type

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9930696.1A GB9930696D0 (en) 1999-12-24 1999-12-24 Novel method of treatment

Publications (1)

Publication Number Publication Date
GB9930696D0 true GB9930696D0 (en) 2000-02-16

Family

ID=10867077

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9930696.1A Ceased GB9930696D0 (en) 1999-12-24 1999-12-24 Novel method of treatment

Country Status (3)

Country Link
AU (1) AU2382701A (en)
GB (1) GB9930696D0 (en)
WO (1) WO2001047520A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007049050A2 (en) * 2005-10-27 2007-05-03 Heptahelix Ab Modulators of gpr40 for the treatment of diabetes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2335597A (en) * 1998-03-27 1999-09-29 Glaxo Group Ltd Stereoisomers of Troglitazone in the Treatment of Diabetes

Also Published As

Publication number Publication date
AU2382701A (en) 2001-07-09
WO2001047520A1 (en) 2001-07-05

Similar Documents

Publication Publication Date Title
GB2351661B (en) Novel method of treatment
IL145875A0 (en) Novel method of treatment
GB0014969D0 (en) Novel method of treatment
HK1027986A1 (en) Method of sterilization
GB9930688D0 (en) Novel method of treatment
GB0008921D0 (en) Method of treatment
AU4598400A (en) Method of treatment
GB9812941D0 (en) Method of treatment
PL349421A1 (en) Novel method of treatment
AU2382601A (en) Novel method of treatment
GB9930696D0 (en) Novel method of treatment
GB0122638D0 (en) Novel method of treatment
GB9930690D0 (en) Novel method of treatment
GB9930692D0 (en) Novel method of treatment
GB9930689D0 (en) Novel method of treatment
GB9915597D0 (en) Method of treatment
GB9903950D0 (en) Method of treatment
TJ99000556A (en) Method of treatment of nevrodermite
EG24158A (en) Novel method of treatment
GB9822681D0 (en) Method of treatment
GB9917181D0 (en) Methods of treatment
GB9901310D0 (en) Methods of treatment
GB9824871D0 (en) Novel method of treatment
GB9824790D0 (en) Novel method of treatment
GB9824789D0 (en) Novel method of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)